The Prince Charles Hospital is a major teaching and tertiary referral hospital in the northern suburb of Chermside in Brisbane, Australia. TPCH is a public hospital operated by Metro North Health, the largest health service in Queensland Health.

There are 663 beds in The Prince Charles Hospital.

During the past decade, The Prince Charles Hospital conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 52 clinical trials were completed, i.e. on average, 45.6% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 31 clinical trials were completed. i.e. 56.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Prince Charles Hospital" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 16 trials, followed by "Abbott Medical Devices" with 13 trials sponsored, "Boston Scientific Corporation" with 13 trials sponsored, "United Therapeutics" with 12 trials sponsored and "Australian and New Zealand Intensive Care Research Centre" with 12 trials sponsored. Other sponsors include 109 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Prince Charles Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 9 trials as a collaborator, "The Prince Charles Hospital" with 6 trials as a collaborator, "The Alfred" with 5 trials as a collaborator, "Monash University" with 4 trials as a collaborator and "Royal Prince Alfred Hospital, Sydney, Australia" with 4 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "The Prince Charles Hospital" are "Cystic Fibrosis" (24 trials), "Pulmonary Arterial Hypertension" (17 trials), "Coronary Artery Disease" (16 trials), "Heart Failure" (11 trials) and "Pulmonary Hypertension" (8 trials). Many other conditions were trialed in "The Prince Charles Hospital" in a lesser frequency.

Most popular intervention types in "The Prince Charles Hospital" are "Drug" (97 trials), "Device" (54 trials), "Other" (24 trials), "Biological" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "IVA" (15 trials), "ELX/TEZ/IVA" (10 trials), "Ralinepag" (4 trials) and "Aspirin" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Prince Charles Hospital" are 179 trials for "All" genders.

Currently, there are 61 active trials in "The Prince Charles Hospital". 2 are not yet recruiting, 29 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 94 completed trials in The Prince Charles Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in The Prince Charles Hospital, 8 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 55 trials that are defined as “Not Applicable".